Journal of Inherited Metabolic Disease

, Volume 11, Issue 2, pp 151–157 | Cite as

Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B

  • T. Levade
  • R. Salvayre
  • A. Maret
  • L. Douste-Blazy
Article

Summary

Epstein-Barr virus-transformed lymphoid cell lines from normal individuals and from patients with Niemann-Pick disease types A, B or C were subjected to various culture conditions in order to study the source of the characteristic lysosomal storage of sphingomyelin observed in the tissues of Niemann-Pick patients. The culture medium was supplemented with a serum substitute devoid of lipoproteins or with one of the following lipid sources: fetal calf serum, human low-density lipoprotein (LDL), or human high-density lipoprotein (HDL). Storage of sphingomyelin was demonstrated under all tested culture conditions in cells deficient in acid sphingomyelinase (Niemann-Pick disease types A and B). In contrast, the sphingomyelin concentration in the lymphoid cell line from a Niemann-Pick type C patient (not deficient in sphingomyelinase) was normal. After more than 30 days in a medium devoid of sphingomyelin, the Niemann-Pick types A and B lymphoid cell lines showed accumulation of sphingomyelin about twice control. The concentration was higher when cells were grown in a medium supplemented with lipids, particularly human LDL or HDL. These results are consistent with the hypothesis that both exogenous and endogenous sphingomyelins participate in the lysosomal storage observed in lymphoid cell lines from patients with Niemann-Pick disease types A and B.

Keywords

Lipid Culture Condition Fetal Calf Serum Normal Individual Exogenous Source 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ames, B. N. Assay of inorganic phosphate, total phosphate and phosphatases.Methods Enzymol. 8 (1966) 115–118Google Scholar
  2. Beaudet, A. L. and Manschreck, A. A. Metabolism of sphingomyelin by intact cultured fibroblasts: differentiation of Niemann-Pick disease types A and B.Biochem. Biophys. Res. Commun. 105 (1982) 14–19Google Scholar
  3. Bes, J. C., Salvayre, R., Levade, T., Caratero, C. and Planel, H. Ultrastructural investigations on two lymphoid cell lines from Niemann-Pick disease type B.Biol. Cell 50 (1984) 299–302Google Scholar
  4. Brady, R. O. Sphingomyelin lipidoses: Niemann-Pick disease. In Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. L. and Brown, M. S. (eds.)The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1983, pp. 831–841Google Scholar
  5. Elleder, M. and Jirasek, A. Niemann-Pick disease.Acta Universitatis Carolinae Medica 29 (1983) 259–267Google Scholar
  6. Fishman, P. H., Bradley, R. M., Brown, M. S., Faust, J. R. and Goldstein, J. L. Similar content of phospholipids and gangliosides in normal and homozygous familial hypercholesterolaemia fibroblasts.J. Lipid Res. 19 (1978) 304–308Google Scholar
  7. Folch, J., Lees, M. and Sloane-Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues.J. Biol. Chem. 226 (1957) 497–509Google Scholar
  8. Forte, T. M., Bell-Quint, J. J. and Cheng, F. Lipoproteins of fetal and newborn calves and adult steer: a study of developmental changes.Lipids 16 (1981) 240–245Google Scholar
  9. Goldstein, J. L. and Brown, M. S. Binding and degradation of low-density lipoproteins by cultured human fibroblasts.J. Biol. Chem. 249 (1974) 5153–5162Google Scholar
  10. Hartree, E. F. Determination of protein: a modification of the Lowry method that gives a linear photometric response.Anal. Biochem. 48 (1972) 422–427Google Scholar
  11. Ho, Y. K., Brown, M. S., Kayden, H. J. and Goldstein, J. L. Binding, internalization and hydrolysis of low-density lipoprotein in long-term lymphoid cell lines from a normal subject and a patient with homozygous familial hypercholesterolaemia.J. Exp. Med. 144 (1976) 444–455Google Scholar
  12. Jackson, R. L., Morrisett, J. D. and Gotto, A. M. Lipoprotein structure and metabolism.Physiol. Rev. 56 (1976) 259–316Google Scholar
  13. Kayden, H. J., Hatam, L. and Beratis, N. G. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and the esterification of cholesterol in human long-term lymphoid cell lines.Biochemistry 15 (1976) 521–528Google Scholar
  14. Kudoh, T., Velkoff, M. A. and Wenger, D. A. Uptake and metabolism of radioactively labelled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.Biochim. Biophys. Acta 754 (1983) 82–92Google Scholar
  15. Leikin, A. I., Mihovilovic, M. and Scanu, A. M. High-density lipoproteins influence cholesterol homeostasis in cultured virus-transformed human lymphoblastoid cells.J. Biol. Chem. 257 (1982) 14280–14287Google Scholar
  16. Levade, T., Salvayre, R., Lenoir, G. and Douste-Blazy, L. Sphingomyelinase and non-specific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.Biochim. Biophys. Acta 793 (1984) 321–324Google Scholar
  17. Levade, T., Salvayre, R. and Douste-Blazy, L. Molecular forms of sphingomyelinase and non-specific phosphodiesterases in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A and B.Eur. J. Biochem. 149 (1985a) 405–409Google Scholar
  18. Levade, T., Salvayre, R., Bes, J. C., Maret, A. and Douste-Blazy, L. Biochemical and ultrastructural findings in a lymphoid cell line from Niemann-Pick disease type A.Biol. Cell 55 (1985b) 143–146Google Scholar
  19. Levade, T., Salvayre, R., Bes, J. C., Nezri, M. and Douste-Blazy, L. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.Pediatr. Res. 19 (1985c) 153–157Google Scholar
  20. Levade, T., Maret, A., Salvayre, R., Livni, N., Rogalle, P. and Douste-Blazy, L. Biochemical and ultrastructural studies on an Epstein-Barr virus-transformed lymphoid cell line from a Niemann-Pick disease type C patient.Biochim. Biophys. Acta. 877 (1986a) 415–422Google Scholar
  21. Levade, T., Salvayre, R. and Douste-Blazy, L. Sphingomyelinases and Niemann-Pick disease.J. Clin. Chem. Clin. Biochem. 24 (1986b) 205–220Google Scholar
  22. Schumaker, V. N. and Puppione, D. L. Sequential flotation ultracentrifugation.Methods Enzymol. 128 (1986) 155–170Google Scholar
  23. Spence, M. W., Clarke, J. T. R. and Cook, H. W. Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects.J. Biol. Chem. 258 (1983) 8595–8600Google Scholar
  24. Sutrina, S. L. and Chen, W. W. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.Biochim. Biophys. Acta 793 (1984) 169–179Google Scholar
  25. Vanier, M. T., Rousson, R., Garcia, I., Bailloud, G., Juge, M. C., Revol, A. and Louisot, P. Biochemical studies in Niemann-Pick disease. III.Clin. Genet. 27 (1985) 20–32Google Scholar
  26. Wenger, D. A. Niemann-Pick disease. In Glew, R. H. and Peters, S. P. (eds.)Practical Enzymology of the Sphingolipidoses, Alan R. Liss, New York, 1977, pp. 39–70Google Scholar

Copyright information

© SSIEM and MTP Press Ltd 1988

Authors and Affiliations

  • T. Levade
    • 1
  • R. Salvayre
    • 1
  • A. Maret
    • 1
  • L. Douste-Blazy
    • 1
  1. 1.INSERM Unité 101 et Laboratoire de Biochimie Médicale, Faculté de Médecine PurpanToulouse CedexFrance

Personalised recommendations